help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuchs, U.
Right arrow Articles by Tarkkanen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuchs, U.
Right arrow Articles by Tarkkanen, A.

American Journal of Pathology, Vol 141, 169-181, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma

U Fuchs, T Kivela, P Summanen, I Immonen and A Tarkkanen
Department of Ophthalmology, Helsinki University Central Hospital, Finland.

A group of 52 patients with malignant uveal melanoma treated by primary enucleation in 1977-1979 was studied to determine the frequency of immunoreactivity for cytokeratins (CK) in primary and metastatic melanoma, the CK types present, and the prognostic significance of CK expression. By immunohistochemistry, monoclonal antibody (MAb) V9 to vimentin reacted with all 52 formalin-fixed, paraffin-embedded primary tumors and all 31 metastases from 11 patients. MAb CAM 5.2 to CK 8 and 18 reacted with 20 and MAb CY-90 to CK 18 with 25 primary melanomas, whereas MAb KS-B17.2 and MAb CK5 to CK 18 labeled 8 and 6 tumors, respectively. Antibodies to CK 13 and CK 19 each labeled single cells in one specimen, and other CK types were not detected. In 6 primary melanomas, only a few tumor cells were immunopositive for CK 8 and 18, but in 17 cases up to one quarter, and in 2 tumors more than one quarter, of them were labeled. The positive cells were spindle, epithelioid, or intermediate in shape, and tended to be more frequent in mixed than in spindle cell melanomas. MAbs CAM 5.2 and CY-90 did not react with any of the 16 liver metastases, but labeled 7 of 15 other metastases. Metastases were somewhat more common when the primary tumor was immunoreactive for CK 8 and 18, apparently because CKs were more frequent in mixed cell melanomas. Although CK expression is of diagnostic significance and can denote low levels of epithelioid differentiation, it is not an independent prognostic factor in malignant uveal melanoma.


This article has been cited by other articles:


Home page
IOVSHome page
P. Toivonen, T. Makitie, E. Kujala, and T. Kivela
Microcirculation and Tumor-Infiltrating Macrophages in Choroidal and Ciliary Body Melanoma and Corresponding Metastases
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R.'a T. Al-Jamal, T. Makitie, and T. Kivela
Nucleolar Diameter and Microvascular Factors as Independent Predictors of Mortality from Malignant Melanoma of the Choroid and Ciliary Body
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2381 - 2389.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Beliveau, M. Berube, P. Carrier, C. Mercier, and S. L. Guerin
Tumorigenicity of the Mixed Spindle-Epithelioid SP6.5 and Epithelioid TP17 Uveal Melanoma Cell Lines Is Differentially Related to {alpha}5{beta}1 Integrin Expression
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3058 - 3065.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Makitie, O. Carpen, A. Vaheri, and T. Kivela
Ezrin as a Prognostic Indicator and Its Relationship to Tumor Characteristics in Uveal Malignant Melanoma
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2442 - 2449.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Kivela, S. Eskelin, T. Makitie, and P. Summanen
Exudative Retinal Detachment from Malignant Uveal Melanoma: Predictors and Prognostic Significance
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2085 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
A. G. M. Scholes, S. Hagan, P. Hiscott, B. E. Damato, and I. Grierson
Overexpression of Epidermal Growth Factor Receptor Restricted to Macrophages in Uveal Melanoma
Arch Ophthalmol, March 1, 2001; 119(3): 373 - 377.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Makitie, P. Summanen, A. Tarkkanen, and T. Kivela
Microvascular Density in Predicting Survival of Patients with Choroidal and Ciliary Body Melanoma
Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2471 - 2480.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Makitie, P. Summanen, A. Tarkkanen, and T. Kivela
Microvascular Loops and Networks as Prognostic Indicators in Choroidal and Ciliary Body Melanomas
J Natl Cancer Inst, February 17, 1999; 91(4): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S E Coupland, N Bechrakis, A Schüler, I Anagnostopoulos, M Hummel, N Bornfeld, and H Stein
Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma
Br. J. Ophthalmol., August 1, 1998; 82(8): 961 - 970.
[Abstract] [Full Text]


Home page
Br. J. Ophthalmol.Home page
T. Kivela and P. Summanen
Retinoinvasive malignant melanoma of the uvea
Br. J. Ophthalmol., August 1, 1997; 81(8): 691 - 697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.